Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Nowadays vaccination of the population living in the endemic regions and widespread implementation of the potent therapies for the emergency prophylaxis and treatment into the clinical practice are regarded as the basic efficient and cost-effective measures for Ebola epidemic spread control. Objecti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: A. A. Petrov, V. N. Lebedev, T. M. Plekhanova, L. F. Stovba, G. V. Borisevich, O. N. Sidorova, O. V. Chukhralya, S. V. Borisevich
Aineistotyyppi: Artigo
Kieli:Russo
Julkaistu: Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2015-09-01
Sarja:Проблемы особо опасных инфекций
Aiheet:
вирус эбола
лекарственные средства
экстренная профилактика и лечение
вирусспецифические антитела
моноклональные антитела
малые интерферирующие рнк
антисмысловые фосфордиамидатные морфолиновые олигомеры
ebola virus
hemorrhagic fever
medical products
emergency prophylaxis and treatment
virus-specific antibodies
monoclonal antibodies
small interfering rna
anti-sense phosphordiamidate morpholine oligomers
Linkit:https://journal.microbe.ru/jour/article/view/254
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia